I could accept that dropping one distributor for two new ones would probably be seen as an 'upgrade' in MGC's potential future revenue streams. However that would only apply if there was no delay between the voiding of HL Pharma deal (if this has occurred) and the signing of these two new Australian distributor agreements. If there was any gap in time between the transition and it was not announced during that transitional period where no Australian distributor was lined up, they would be in breach of their obligations IMO.
Ann: Definitive Supply Agreement Executed with HL Pharma, page-147
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.040(16.0%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 29.0¢ | 26.5¢ | $11.92K | 41.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1812 | 1 |
View Market Depth
| Last trade - 14.32pm 07/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |